DUFFIELD JEREMY enters PRIME MEDICINE, INC. with 965K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/19/2022ACC: 0001628280-22-026676
Officer· Chief Scientific Officer
Since Oct 2022
965K
Baseline shares
100% direct
965K
Direct ownership
1 position
16.08K
Derivative underlying
1 instrument
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned965K
Total
965K direct965K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 965K | Direct |
| Total | 965K | 965K direct |
Derivative Holdings1
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
16.08K
Shares owned
N/A
Exercise price
3.67
Expiration
—
Exercise window
—
Total
Underlying
16.08K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 3.67 | — | — | 16.08K | N/A |
| Total | 16.08K | 0.00 | ||||